ENTRY       D06356                      Drug
NAME        Zanolimumab (USAN/INN)
EFFICACY    Antineoplastic, Antirheumatic, Anti-CD4 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of rheumatoid arthritis, psoriasis, cutaneous and peripheral T-cell lymphoma
TARGET      CD4 [HSA:920] [KO:K06454]
  PATHWAY   hsa04060(920)  Cytokine-cytokine receptor interaction
            hsa04514(920)  Cell adhesion molecules
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                CD4
                 D06356  Zanolimumab (USAN/INN)
DBLINKS     CAS: 652153-01-0
            PubChem: 47208013
            NIKKAJI: J2.415.692C
///
